乌鸦传媒

<乌鸦传媒 class='mpt-top_cat_title'>Oncology/Hematology >

Leukemia

News, opinions and meeting coverage in oncology/hematology.

2019 SIR Meeting Convention in Austin, Texas

<乌鸦传媒>Are Patients Better Off With Image-Guided Bone Marrow Biopsy?

Prospect of sedation has some going to interventional radiology

<乌鸦传媒>Increased Risk of Chemo-Associated AML for Nearly All Solid Cancers

Extended beyond 5 years for most types with greater risk seen in young patients

<乌鸦传媒>Higher Risk of Shingles Seen in Patients With Certain Cancers

Vaccine development may help with prevention of herpes zoster in this population

<乌鸦传媒>ASH Poster Rounds: Obesity Impacts CLL Survival in Women

Plus: New risk model predicts CLL survival; novel BTK inhibitor works after ibrutinib

<乌鸦传媒>Chemo-Free Tx Tops Best Option in Younger CLL Patients

Improved overall survival and safety with ibrutinib-based therapy

<乌鸦传媒>Add-On Drugs Could Boost Efficacy, Tolerability of CAR T-Cell Therapies

Studies test addition of targeted agents, immunotherapy

<乌鸦传媒>CAR T-Cell Responses Prove Durable in ALL, DLBCL

Two studies demonstrate long-term control in relapsed/refractory disease

<乌鸦传媒>Ibrutinib Alone Wins in Older CLL Patients

Adding rituximab offered no added benefit

<乌鸦传媒>Sneak Peek at Practice-Changing Research From ASH 2018

"Big trials, big results," plus sickle cell disease and CAR T-cell therapies

<乌鸦传媒>Levaquin With Chemo Reduces Bacteremia in Pediatric AML/ALL

But no advantage seen among those undergoing transplant

<乌鸦传媒>FDA Warns Against Long-Term Zmax Use in Certain Cancer Patients

Heightened risk of relapse, death seen in study of stem cell transplant recipients

<乌鸦传媒>Decades Later, Mortality for Childhood Transplant Recipients Remains High

Elevated risk requires closer follow-up care

<乌鸦传媒>Nothing Good for Older Lung Cancer Patients From Add-On Cisplatin

Two trials show no survival benefit and more toxicity

<乌鸦传媒>Second Transplant vs Donor Lymphocyte Infusion in Relapsed AML

Both options viable, benefit more clear in certain groups

<乌鸦传媒>FLT3-ITD Inhibitor Improves Survival in Relapsed AML

More quizartinib-treated patients went on to stem cell transplant

<乌鸦传媒>Lymphoma Risk with JAK Inhibitors for MPNs

Preexisting aberrant B-cell clone implicated

<乌鸦传媒>Ivosidenib Induces Deep Remissions in IDH1-Mutant AML

On strength of phase I data, drug appears headed for FDA approval

<乌鸦传媒>Algorithm Helps Manage Fever

Pediatric cancer patients with non-neutropenic fever could benefit

<乌鸦传媒>Make the Diagnosis: What鈥檚 to Blame for his Rash and Paresthesia?

Case Findings: A 52-year-old man who was undergoing chemotherapy for leukemia went to the ED 5 days after receiving cytarabine. He complained of a rapid onset of erythematous lesions on his palms and soles accompanied by tingling and burning sensations. Can you diagnose the patient?

<乌鸦传媒>New Clues to CAR T-Cell Failure

Chemo effects, T cell energy sources

<乌鸦传媒>Gladiator Blood and Liquid Gold: Good for What Ails You?

A new book by Lydia Kang, MD, reviews the most dubious cures in history

<乌鸦传媒>Mixed Results with Regimens for Older AML Patients

Positive data with venetoclax, liposomal cytarabine-daunorubicin

<乌鸦传媒>Vince DeVita鈥檚 Oncology Opus

Medicine and music share center stage in storied career

<乌鸦传媒>MSK Cancer Alliance: Mainly About Medicine

Bi-directional relationship strengthens regional cancer care

<乌鸦传媒>Bangladesh-Boston Collaborate on ASCT Center

Two dozen patients undergo successful stem cell transplant in Dhaka

<乌鸦传媒>Can Patients With Stable CML Stop Drug Therapy?

Studies examine TKI cessation and dose reduction

<乌鸦传媒>Survival Boost With Liposomal Tx in Older AML Patients

Agent may also provide a bridge to successful transplant

<乌鸦传媒>CML Patients Still Benefit from Transplant

Also at SOHO: Ponatinib proves mettle in pretreated CML

<乌鸦传媒>Hypomethylating Agents Useful in Low-Risk MDS

Objective responses in a majority of patients

<乌鸦传媒>Gross Anatomy: When Orchids Attack!

Also, a mysterious case of sandpapery skin

<乌鸦传媒>Antitibiotic-Chemo Combo Cuts Infection Risk in AML

Incidence of Streptococcus viridans more than halved with prophylaxis.

<乌鸦传媒>Part 2: Oncologists Weigh In on PBS Cancer Documentary

Six specialists share their impressions of Ken Burns' cancer opus.

<乌鸦传媒>Jakafi Requires Careful Dosing Early: Experts

NEW YORK -- The JAK inhibitor can make a big difference for myelofibrosis patients, but must be monitored.

<乌鸦传媒>OncoBlog: Driving the CAR to a Cancer Cure?

Is immunotherapy with chimeric antigen receptor (CAR)-directed T cells the "next big thing" in oncology? Presentations and discussion at a recent conference suggest the technology has considerable promise -- but will it qualify as a breakthrough? OncoBlog is a blog by the Medpage Today staff for readers with an interest in oncology. This post comes from Charles Bankhead.

<乌鸦传媒>Gene Therapy Works in SCID With No Risk of Leukemia

NEW ORLEANS -- Genetic therapy appeared to restore the immune system of patients with X-linked severe combined immunodeficiency (SCID), but without leading to leukemia as a side effect, researchers reported here.

<乌鸦传媒>Polycythemia Vera Better with Low Hematocrit

ATLANTA -- Maintaining patients with polycythemia vera at hematocrit levels below 45% reduced thrombotic complications without increasing rates of other serious adverse events.

<乌鸦传媒>Clinical Notes: Beware the Seat Heater

乌鸦传媒 debuts a new regular feature, a roundup of clinical news you might otherwise have missed. This week we led with a report that heated car seats can leave passengers with "toasted skin syndrome."

<乌鸦传媒>AMA Adopts Policies on Circumcision, Gun Safety

The American Medical Association (AMA) House of Delegates has adopted a number of new policies at its interim meeting, including policies on male circumcision, physician discussion of gun safety, and a new medical coding system that will go into effect in 2013.

<乌鸦传媒>ASCO: Methotrexate Boost Improves ALL Outcomes

CHICAGO -- There's new life in an old drug for high-risk acute lymphoblastic leukemia (ALL).

<乌鸦传媒>CBS Newsman Ed Bradley Dies of CLL Complications

NEW YORK -- Veteran television journalist Ed Bradley has died of complications of chronic lymphocytic leukemia (CLL) at the age of 65.

5